NF-κB in biology and targeted therapy: new insights and translational implications

NF-κB в биологии и таргетной терапии: новые представления и трансляционные перспективы
Jian Zhang, Xinyu Chen, Qing Guo, Yizi Jin, Xiaomin Ye, Xin Shen, Mingxi Lin, Cheng Zeng, Teng Zhou
2024-03-03

IKK inhibitorsNF-κB signalinginflammatory responsestargeted therapytumor microenvironment
NF-κB signaling has been discovered for nearly 40 years. Initially, NF-κB signaling was identified as a pivotal pathway in mediating inflammatory responses. However, with extensive and in-depth investigations, researchers have discovered that its role can be expanded to a variety of signaling mechanisms, biological processes, human diseases, and treatment options. In this review, we first scrutinize the research process of NF-κB signaling, and summarize the composition, activation, and regulatory mechanism of NF-κB signaling. We investigate the interaction of NF-κB signaling with other important pathways, including PI3K/AKT, MAPK, JAK-STAT, TGF-β, Wnt, Notch, Hedgehog, and TLR signaling. The physiological and pathological states of NF-κB signaling, as well as its intricate involvement in inflammation, immune regulation, and tumor microenvironment, are also explicated. Additionally, we illustrate how NF-κB signaling is involved in a variety of human diseases, including cancers, inflammatory and autoimmune diseases, cardiovascular diseases, metabolic diseases, neurological diseases, and COVID-19. Further, we discuss the therapeutic approaches targeting NF-κB signaling, including IKK inhibitors, monoclonal antibodies, proteasome inhibitors, nuclear translocation inhibitors, DNA binding inhibitors, TKIs, non-coding RNAs, immunotherapy, and CAR-T. Finally, we provide an outlook for research in the field of NF-κB signaling. We hope to present a stereoscopic, comprehensive NF-κB signaling that will inform future research and clinical practice.
1
Dysregulated NF-κB signaling contributes to cancers, inflammatory and autoimmune disorders, cardiovascular and metabolic diseases, neurological diseases, and COVID-19.
2
NF-κB has complex physiological and pathological roles in inflammation, immune regulation, and the tumor microenvironment.
3
NF-κB interacts extensively with PI3K/AKT, MAPK, JAK-STAT, TGF-β, Wnt, Notch, Hedgehog, and TLR pathways.
4
NF-κB signaling extends beyond inflammatory responses to regulate diverse signaling mechanisms, biological processes, and human diseases.
5
Therapeutic strategies targeting NF-κB include IKK inhibitors, monoclonal antibodies, proteasome and nuclear-translocation inhibitors, DNA-binding inhibitors, TKIs, non-coding RNAs, immunotherapy, and CAR-T approaches.

NF-κB signaling in biological and disease contexts

The composition, activation, regulatory mechanisms, pathway interactions, biological and pathological roles, disease involvement, and therapeutic targeting of NF-κB signaling

Publication Details
Publication Date
2024-03-03
Journal
Publisher
ISSN
Cited by
2084
Access Type
Author Information
Authors
Jian Zhang
Xinyu Chen
Qing Guo
Yizi Jin
Xiaomin Ye
Xin Shen
Mingxi Lin
Cheng Zeng
Teng Zhou
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%